FDA officials, patient representatives and industry stakeholders said the hiring provisions included in the drug user fee commitment letter are critical to the other goals outlined for the sixth iteration of the program, with an industry representative saying FDA’s ability to recruit scientists is crucial to the agency keeping pace with scientific advancement. But as the agency and stakeholders discussed the proposed recommendations for the Prescription Drug User Fee Act at a meeting Monday (Aug. 15), Avalere released an analysis...